microfluidics
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.
Altratech Nabs €10.5M in Financing to Support POC Test Development, Commercialization
The Ireland-based firm said that the financing will support clinical trials of an HIV test and help the company to strengthen its product pipeline.
AMDI Developing 10-Minute Point-of-Care PCR System, Pursuing CLIA Waiver for Respiratory Panel
Premium
The Fast PCR System uses novel sample prep, ultra-fast PCR, and spinning disk-based microfluidics.
Roche to Acquire LumiraDx Point-of-Care Testing Tech for up to $350M
Roche expects to integrate the POC clinical chemistry and immunoassay tests into its Diagnostics business when the acquisition closes in mid-2024.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
Dec 16, 2022
Nov 18, 2022
Jun 17, 2022
Jun 3, 2022
May 20, 2021
Mar 31, 2021